Kiyle Huntsing
Donec sed odio operae, eu vulputate felis rhoncus. Paullum deliquit, ponderibus modulisque suis ratio utitur. Ab illo tempore, ab est sed immemorabili.
Donec sed odio operae, eu vulputate felis rhoncus. Paullum deliquit, ponderibus modulisque suis ratio utitur. Ab illo tempore, ab est sed immemorabili.
FDA’s Office of Hematology and Oncology Products Reorganizes
Learn MoreAACR Virtual Annual Meeting II: Why Are Cancer Rates Increasing Among Young Adults?
Learn MoreHighlights from the AACR Annual Meeting 2018
Learn MoreFDA Expands Use of Immunotherapeutic to Kidney Cancer
Learn MoreSexual Health and Other Lifestyle Considerations for Breast Cancer Survivors
Learn More2025 AACR Journal Awards Highlight Broad Scope of Oncology-advancing Research
Learn MoreWorld Cancer Day: Get the Facts
Learn MoreCervical Cancer: A Cautionary Tale of Optimism and Challenges
Learn MoreFDA Approves New Treatment for HER2-positive Breast Cancer
Learn MoreAACR Disparities Meeting: The Impact of Structural Racism on Breast Cancer Outcomes
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: